(Press-News.org) WHO PQ paves the way for public procurement of SKYTyphoid™ by UN organizations
Addition of new vaccine will diversify, expand TCV supply amid expected growing demand
February 23, 2024, SEOUL, Korea – SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.
WHO PQ certifies the safety, efficacy, and GMP of a vaccine by evaluating its manufacturing process, quality, and clinical trial results according to stringent standards. WHO PQ is essential for participating in international tenders organized by UN agencies including UNICEF and the Pan American Health Organization (PAHO) and certifies the quality of the vaccine and the competitiveness of technology in the global market.
The new vaccine SKYTyphoid™, which has received the WHO’s seal of approval this time, is a typhoid conjugate vaccine developed jointly by SK bioscience and IVI following IVI’s technology transfer with funding support from the Bill & Melinda Gates Foundation. SK bioscience was the manufacturing partner and IVI led clinical trials conducted in the Philippines and Nepal.
The vaccine utilizes the ‘purified Vi polysaccharide-diphtheria toxoid conjugate’ method, which conjugates diphtheria toxin protein (diphtheria toxoid), which acts as a carrier, to polysaccharide of typhoid bacteria, which acts as an antigen. Adopting conjugation technology, the vaccine is safe to administer in infants and young children aged 6 months to 2 years and is expected to provide sufficient immune response and long-term protection with a single dose compared to existing oral live or polysaccharide typhoid vaccines.
Based on clinical results, SKYTyphoid™ obtained a licensure for export from the Korean Ministry of Food and Drug Safety in 2022. A Phase 3 clinical trial conducted by SK bioscience and IVI in Nepal on 2,160 healthy individuals aged 6 months to 45 years had confirmed the excellent immunogenicity and safety of the vaccine. In the comparative study with a conventional WHO-PQed polysaccharide-protein conjugate typhoid vaccine, SKYTyphoid™ demonstrated equivalent immunogenicity and safety, without any notable side effect after administration across all age groups. The findings were published in The Lancet Infectious Diseases, a sister publication to the journal The Lancet.
Additionally, the results of the Phase II clinical trial of SKYTyphoid™ booster shot, published in the international ‘npj (Nature Partner Journal) Vaccine,’ showed that two doses of the TCV in infants aged 6 to 23 months induced a strong immune response, with a significant increase in antibody titers in the body compared to before vaccination.
Dr. Sushant Sahastrabuddhe, Director of IVI’s Typhoid program, said “The WHO licensure of SK bioscience’s TCV represents the successful conclusion of a global public-private partnership to bring a novel vaccine crucial to global public health to market. SKYTyphoid™ will diversify and expand the supply of TVCs and help improve vaccine access in the endemic countries. With SK’s commitment to make the vaccine for global public health at a competitive price, SKYTyphoid™ will play an important role in typhoid prevention globally.”
With high demand for typhoid vaccines worldwide, especially in low-income countries, SK bioscience plans to start supplying the vaccine as soon as possible and expand global supply through public procurement markets including typhoid endemic countries. According to the WHO, an estimated 11 to 20 million typhoid fever cases occur worldwide every year, and 120,000 to 160,000 die from the disease.
Dr. Jerome Kim, Director General of IVI said, “Typhoid fever is more prevalent in warmer temperatures, and climate change and the worrying rise of antimicrobial resistance are only adding to the threat of the disease. Vaccination is critical to effective prevention and control of the disease. In collaboration with SK bioscience and other partners, IVI will continue endeavors to make this vaccine accessible to people who need them the most.”
Mr. Jae-Yong Ahn, President of SK bioscience said, “We are pleased that our global collaboration to address the global vaccine supply imbalance and improve public health has been recognized through the WHO PQ. In addition to the WHO PQ, we will obtain additional country-specific approvals to ensure that the vaccine can be supplied quickly.” With the addition of ‘SKYtyphoid™,’ SK bioscience has now achieved WHO PQ for four vaccines, including two influenza vaccines and a chickenpox vaccine.
END
SK bioscience’s typhoid conjugate vaccine achieves WHO prequalification
WHO PQ paves the way for public procurement of SKYTyphoid™ by UN organizations
2024-02-23
ELSE PRESS RELEASES FROM THIS DATE:
The American College of Medical Genetics and Genomics (ACMG) releases points to consider statement on the safety and efficacy of polygenic risk score assessment for embryo selection
2024-02-23
Should we be using polygenic risk score assessment for embryo selection? Providing in-depth analysis, the Social, Ethical and Legal Issues Committee of the American College of Medical Genetics and Genomics (ACMG) has released a new Points to Consider statement to assist healthcare professionals and patients in understanding the safety and utility of preimplantation genetic testing for polygenic disorders (PGT-P) as a clinical service.
“Clinical Utility of Polygenic Risk Scores for Embryo Selection: A Points to Consider Statement of the American College of Medical Genetics and Genomics (ACMG)” was published in the College’s flagship journal, Genetics ...
PolyU researchers introduce biomineralisation as a sustainable strategy against microbial corrosion in marine concrete
2024-02-23
Microbially induced corrosion (MIC) is a prevalent issue in marine environments, leading to structural damages such as cracking in concrete infrastructure. This corrosion poses a persistent challenge, significantly reducing the lifespan of marine structures and resulting in substantial economic losses. In response to the need for an effective solution to combat the marine corrosion on concrete, researchers of the Hong Kong Polytechnic University have developed a biomineralization approach to protect marine concrete from MIC.
Prof. ...
UBC Okanagan researchers look to the past to improve construction sustainability
2024-02-23
Researchers at UBC Okanagan are revisiting old building practices—the use of by-products and cast-offs—as a way to improve building materials and sustainability of the trade.
A technique known as rammed earth construction uses materials that are alternatives to cement and are often more readily available in the environment. One such alternative is wood fly ash, a by-product of pulp mills and coal-fired power plants, explains Dr. Sumi Siddiqua, with UBC Okanagan’s School of Engineering.
Industry has been trying to find a use for materials like fly ash ...
New study identifies potential gene targets for management of cassava whitefly, key vector of viral diseases threatening African food security
2024-02-23
Whiteflies, particularly the African cassava whitefly (Bemisia tabaci, SSA1-SG1), pose a significant threat to agricultural productivity in Sub-Saharan Africa by transmitting viruses that cause cassava brown streak disease and cassava mosaic virus disease. In a new study published in PeerJ Life & Environment, Dr. Tadeo Kaweesi and his team at the National Agricultural Research Organization identify potential gene targets that could revolutionize the management of this devastating pest and prove vital for food security in the region.
In the article ("In silico prediction of candidate gene targets ...
Twin, the new robotic exoskeleton for lower limbs
2024-02-23
Milan (Italy), 23 February 2024 – TWIN is the name of the new robotic exoskeleton for lower limbs, designed and developed by Rehab Technologies IIT – INAIL, the joint laboratory between the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and the Prosthetic Center of INAIL (the prosthetic unit of the National Institute for Insurance against Accidents at Work), which will allow patients to wear it more easily. Presented today in Milan during a press conference held at the Museum of Science and Technology, TWIN was demonstrated ...
Mass shooting lockdown drills help schoolchildren feel safer, US study suggests
2024-02-23
Lockdown drills, practiced to help prepare children for shooting incidents at school, make those who have been exposed to violence feel safer – a new study of thousands of students in the US indicates.
The finding, reported in a new peer-reviewed paper published in the Journal of School Violence, contradicts claims that the drills traumatize children, without making them feel safer.
Ensuring that students feel safe – and are safe – in schools is essential for them to learn and thrive, explains ...
Wake-up call for us all to establish regular healthy sleeping patterns
2024-02-23
t’s official. Getting the recommended 7-9 hours of sleep a night is currently out of reach for almost one-third of the population as Flinders University experts found 31% of adults had average sleep durations outside the recommended range.
The global study of thousands of adults published in Sleep Health found only 15% of people slept the recommended 7-9 hours for five or more nights per week – and among those who did achieve an average of 7-9 hours per night over the nine month monitoring period, about 40% ...
Using mussels and silkworm cocoons to stop organ bleeding
2024-02-23
In recent news, there has been a case where a patient experienced pain due to a surgical procedure involving sutures, resulting in the unintended presence of gauze within the patient's body. Gauze is typically employed to control bleeding during medical interventions, aiding in hemostasis. However, when inadvertently left in the body, it can lead to inflammation and infection. Addressing this issue, recent research has been published by researchers focusing on a hemostatic agent derived from mussels and silkworm cocoons. This hemostatic agent has garnered attention in the academic community due to its efficacy in clotting blood and its safety within ...
New research reveals how cancer hijacks immune cells to promote tumour growth
2024-02-23
A new research study led by A*STAR.Singapore Immunology Network (A*STAR.SIgN) has found that neutrophils—one of the most abundant white blood cells in our body—change drastically in certain cancers, adopting a new function whereby they promote tumour growth. By carefully studying neutrophils as soon as they enter the tumour, scientists from A*STAR.SIgN also uncovered ways to accurately differentiate tumour-promoting neutrophils from normal neutrophils present in the rest of the body. Neutrophils play important and irreplaceable roles in fighting infections, ...
Gene regulatory network inference based on causal discovery integrating with graph neural network
2024-02-23
Gene regulatory networks (GRNs) depict the regulatory mechanisms of genes within cellular systems as a network, offering vital insights for understanding cell processes and molecular interactions that determine cellular phenotypes. Transcriptional regulation, a prevalent type for regulating gene expression, involves the control of target genes (TGs) by transcription factors (TFs). One of the major challenges in inferring GRNs is to establish causal relationships, rather than just correlation, among the various components ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] SK bioscience’s typhoid conjugate vaccine achieves WHO prequalificationWHO PQ paves the way for public procurement of SKYTyphoid™ by UN organizations